C-MER Medical Holdings Limited (HKG:3309)
Hong Kong · Delayed Price · Currency is HKD 1.040
-0.020 (-1.89%)
Jun 5, 2026, 3:11 PM HKT
C-MER Medical Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,237 | 2,047 | 2,454 | 4,294 | 6,206 | 7,926 | |
Market Cap Growth | -40.54% | -16.61% | -42.85% | -30.80% | -21.70% | 20.36% |
Enterprise Value | 1,359 | 2,192 | 2,506 | 4,228 | 6,137 | 7,673 |
Last Close Price | 1.04 | 1.72 | 1.99 | 3.40 | 4.85 | 6.81 |
PE Ratio | 12.49 | 20.39 | - | 69.27 | - | 362.56 |
Forward PE | - | 34.42 | 34.42 | 34.42 | 34.42 | 34.42 |
PS Ratio | 0.64 | 1.05 | 1.28 | 2.23 | 3.58 | 7.12 |
PB Ratio | 0.64 | 1.06 | 1.30 | 2.15 | 3.11 | 5.93 |
P/TBV Ratio | 1.22 | 2.02 | 2.33 | 4.12 | 5.94 | 7.03 |
P/FCF Ratio | 6.01 | 9.95 | 19.71 | 17.48 | 81.81 | 301.86 |
P/OCF Ratio | 4.36 | 7.22 | 8.67 | 11.89 | 37.64 | 54.89 |
EV/Sales Ratio | 0.70 | 1.13 | 1.31 | 2.20 | 3.54 | 6.90 |
EV/EBITDA Ratio | 3.99 | 10.61 | 12.38 | 20.72 | 66.50 | 127.82 |
EV/EBIT Ratio | 9.57 | 15.37 | 19.45 | 33.95 | 1453.13 | 929.93 |
EV/FCF Ratio | 6.60 | 10.65 | 20.13 | 17.21 | 80.90 | 292.22 |
Debt / Equity Ratio | 0.22 | 0.22 | 0.23 | 0.18 | 0.23 | 0.35 |
Debt / EBITDA Ratio | 1.25 | 1.25 | 1.28 | 1.05 | 1.98 | 3.01 |
Debt / FCF Ratio | 2.07 | 2.07 | 3.52 | 1.48 | 5.97 | 17.96 |
Net Debt / Equity Ratio | -0.02 | -0.02 | -0.02 | -0.10 | -0.12 | 0.02 |
Net Debt / EBITDA Ratio | -0.19 | -0.19 | -0.15 | -0.95 | -2.67 | 0.49 |
Net Debt / FCF Ratio | -0.19 | -0.19 | -0.24 | -0.79 | -3.24 | 1.12 |
Asset Turnover | 0.71 | 0.71 | 0.70 | 0.68 | 0.71 | 0.62 |
Inventory Turnover | 25.32 | 25.32 | 28.03 | 26.75 | 28.52 | 25.34 |
Quick Ratio | 1.18 | 1.18 | 1.32 | 1.60 | 1.45 | 1.17 |
Current Ratio | 1.43 | 1.43 | 1.56 | 1.85 | 1.63 | 1.83 |
Return on Equity (ROE) | 5.81% | 5.81% | -5.58% | 4.33% | -2.77% | 1.23% |
Return on Assets (ROA) | 3.27% | 3.27% | 2.95% | 2.75% | 0.11% | 0.29% |
Return on Invested Capital (ROIC) | 5.37% | 5.42% | 7.04% | 4.87% | 0.27% | 0.42% |
Return on Capital Employed (ROCE) | 6.30% | 6.30% | 5.60% | 5.30% | 0.20% | 0.50% |
Earnings Yield | 8.12% | 4.90% | -5.51% | 1.44% | -0.35% | 0.28% |
FCF Yield | 16.64% | 10.05% | 5.07% | 5.72% | 1.22% | 0.33% |
Dividend Yield | 1.89% | 1.16% | 1.01% | - | - | - |
Payout Ratio | 28.77% | 28.77% | - | - | - | 105.06% |
Buyback Yield / Dilution | 2.25% | 2.25% | 1.77% | -1.82% | -7.16% | -4.22% |
Total Shareholder Return | 4.14% | 3.42% | 2.77% | -1.82% | -7.16% | -4.22% |